294 related articles for article (PubMed ID: 32334605)
1. Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry.
Patterson MC; Mengel E; Vanier MT; Moneuse P; Rosenberg D; Pineda M
Orphanet J Rare Dis; 2020 Apr; 15(1):104. PubMed ID: 32334605
[TBL] [Abstract][Full Text] [Related]
2. Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study.
Patterson MC; Mengel E; Vanier MT; Schwierin B; Muller A; Cornelisse P; Pineda M;
Orphanet J Rare Dis; 2015 May; 10():65. PubMed ID: 26017010
[TBL] [Abstract][Full Text] [Related]
3. Disease and patient characteristics in NP-C patients: findings from an international disease registry.
Patterson MC; Mengel E; Wijburg FA; Muller A; Schwierin B; Drevon H; Vanier MT; Pineda M
Orphanet J Rare Dis; 2013 Jan; 8():12. PubMed ID: 23324478
[TBL] [Abstract][Full Text] [Related]
4. Clinical disease characteristics of patients with Niemann-Pick Disease Type C: findings from the International Niemann-Pick Disease Registry (INPDR).
Bolton SC; Soran V; Marfa MP; Imrie J; Gissen P; Jahnova H; Sharma R; Jones S; Santra S; Crushell E; Stampfer M; Coll MJ; Dawson C; Mathieson T; Green J; Dardis A; Bembi B; Patterson MC; Vanier MT; Geberhiwot T
Orphanet J Rare Dis; 2022 Feb; 17(1):51. PubMed ID: 35164809
[TBL] [Abstract][Full Text] [Related]
5. Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C.
Héron B; Valayannopoulos V; Baruteau J; Chabrol B; Ogier H; Latour P; Dobbelaere D; Eyer D; Labarthe F; Maurey H; Cuisset JM; de Villemeur TB; Sedel F; Vanier MT
Orphanet J Rare Dis; 2012 Jun; 7():36. PubMed ID: 22676771
[TBL] [Abstract][Full Text] [Related]
6. Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect.
Nadjar Y; Hütter-Moncada AL; Latour P; Ayrignac X; Kaphan E; Tranchant C; Cintas P; Degardin A; Goizet C; Laurencin C; Martzolff L; Tilikete C; Anheim M; Audoin B; Deramecourt V; De Gaillarbois TD; Roze E; Lamari F; Vanier MT; Héron B
Orphanet J Rare Dis; 2018 Oct; 13(1):175. PubMed ID: 30285904
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of miglustat in Niemann-Pick C disease: a single centre experience.
Ginocchio VM; D'Amico A; Bertini E; Ceravolo F; Dardis A; Verrigni D; Bembi B; Dionisi-Vici C; Deodato F
Mol Genet Metab; 2013 Nov; 110(3):329-35. PubMed ID: 23973268
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival outcomes of patients with Niemann-Pick disease type C receiving miglustat treatment: A large retrospective observational study.
Patterson MC; Garver WS; Giugliani R; Imrie J; Jahnova H; Meaney FJ; Nadjar Y; Vanier MT; Moneuse P; Morand O; Rosenberg D; Schwierin B; Héron B
J Inherit Metab Dis; 2020 Sep; 43(5):1060-1069. PubMed ID: 32324281
[TBL] [Abstract][Full Text] [Related]
9. Miglustat in Niemann-Pick disease type C patients: a review.
Pineda M; Walterfang M; Patterson MC
Orphanet J Rare Dis; 2018 Aug; 13(1):140. PubMed ID: 30111334
[TBL] [Abstract][Full Text] [Related]
10. Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann-Pick disease Type C: an international, multicenter, retrospective chart review.
Pineda M; Juríčková K; Karimzadeh P; Kolnikova M; Malinova V; Insua JL; Velten C; Kolb SA
Orphanet J Rare Dis; 2019 Jan; 14(1):32. PubMed ID: 30732631
[TBL] [Abstract][Full Text] [Related]
11. Miglustat in patients with Niemann-Pick disease Type C (NP-C): a multicenter observational retrospective cohort study.
Pineda M; Wraith JE; Mengel E; Sedel F; Hwu WL; Rohrbach M; Bembi B; Walterfang M; Korenke GC; Marquardt T; Luzy C; Giorgino R; Patterson MC
Mol Genet Metab; 2009 Nov; 98(3):243-9. PubMed ID: 19656703
[TBL] [Abstract][Full Text] [Related]
12. Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann-Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report.
Cuisset JM; Sukno S; Trauffler A; Latour P; Dobbelaere D; Michaud L; Vallée L
J Med Case Rep; 2016 Sep; 10(1):241. PubMed ID: 27599728
[TBL] [Abstract][Full Text] [Related]
13. [Adult onset Niemann-Pick type C disease and psychosis: literature review].
Maubert A; Hanon C; Metton JP
Encephale; 2013 Oct; 39(5):315-9. PubMed ID: 23928063
[TBL] [Abstract][Full Text] [Related]
14. Treatment of a child diagnosed with Niemann-Pick disease type C with miglustat: a case report in Brazil.
Santos ML; Raskin S; Telles DS; Löhr A; Liberalesso PB; Vieira SC; Cordeiro ML
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S357-61. PubMed ID: 18937049
[TBL] [Abstract][Full Text] [Related]
15. Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C.
Fecarotta S; Romano A; Della Casa R; Del Giudice E; Bruschini D; Mansi G; Bembi B; Dardis A; Fiumara A; Di Rocco M; Uziel G; Ardissone A; Roccatello D; Alpa M; Bertini E; D'Amico A; Dionisi-Vici C; Deodato F; Caviglia S; Federico A; Palmeri S; Gabrielli O; Santoro L; Filla A; Russo C; Parenti G; Andria G
Orphanet J Rare Dis; 2015 Feb; 10():22. PubMed ID: 25888393
[TBL] [Abstract][Full Text] [Related]
16. Effects of miglustat therapy on neurological disorder and survival in early-infantile Niemann-Pick disease type C: a national French retrospective study.
Freihuber C; Dahmani-Rabehi B; Brassier A; Broué P; Cances C; Chabrol B; Eyer D; Labarthe F; Latour P; Levade T; Pichard S; Sevin C; Vanier MT; Héron B
Orphanet J Rare Dis; 2023 Jul; 18(1):204. PubMed ID: 37480097
[TBL] [Abstract][Full Text] [Related]
17. Early detection of Niemann-pick disease type C with cataplexy and orexin levels: continuous observation with and without Miglustat.
Imanishi A; Kawazoe T; Hamada Y; Kumagai T; Tsutsui K; Sakai N; Eto K; Noguchi A; Shimizu T; Takahashi T; Han G; Mishima K; Kanbayashi T; Kondo H
Orphanet J Rare Dis; 2020 Sep; 15(1):269. PubMed ID: 32993765
[TBL] [Abstract][Full Text] [Related]
18. Effects of miglustat on stabilization of neurological disorder in niemann-pick disease type C: Iranian pediatric case series.
Karimzadeh P; Tonekaboni SH; Ashrafi MR; Shafeghati Y; Rezayi A; Salehpour S; Ghofrani M; Taghdiri MM; Rahmanifar A; Zaman T; Aryani O; Shoar BN; Shiva F; Tavasoli A; Houshmand M
J Child Neurol; 2013 Dec; 28(12):1599-606. PubMed ID: 23143717
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Dysphagia and Longitudinal Changes in Swallowing Function in Adults with Niemann-Pick Disease Type C Treated with Miglustat.
Lewis C; Keage M; Watanabe M; Schubiger D; Velakoulis D; Walterfang M; Vogel AP
Dysphagia; 2021 Jun; 36(3):362-373. PubMed ID: 32562141
[TBL] [Abstract][Full Text] [Related]
20. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study.
Patterson MC; Vecchio D; Prady H; Abel L; Wraith JE
Lancet Neurol; 2007 Sep; 6(9):765-72. PubMed ID: 17689147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
